BridgeMD
New treatment option for Hip Osteoarthritis
Official title The Ace Avanteon Study - A Randomized Controled Trial
ClinicalTrials.gov ID: NCT06499038
What this study is testing
- What it's testing
- The goal of this randomized controled trial is to compare if using of ancillary screws yields equal results as no use of ancillary screws in the ACE acetabulum cup of a total hip arthroplasty. Further, the migration of the Avanteon stem over time will be assessed.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 65 to 80
You may be able to join if
- Patients with primary hip osteoarthritis between the age of 65 and 80 years at time of surgery
- Patients requiring primary total hip replacement
- Patients who understand the conditions of the study, are willing to, and able to comply with the postoperative scheduled clinical and radiographic...
You likely can't join if
- Patients who are unable to provide informed consent
- Patients who require revision hip arthroplasty
- Patients who have had a previous osteotomy or osteosynthesis of the femur or acetabulum
- Patients with metabolic bone disease, other than osteoporosis
- Patients with inflammatory arthritis
- Obese patients where obesity is severe enough to affect the patient's ability to perform activities of daily living (BMI \> 40)
See the full eligibility criteria
- Patients with primary hip osteoarthritis between the age of 65 and 80 years at time of surgery
- Patients requiring primary total hip replacement
- Patients who understand the conditions of the study, are willing to, and able to comply with the postoperative scheduled clinical and radiographic evaluations
- Patients who are unable to provide informed consent
- Patients who require revision hip arthroplasty
- Patients who have had a previous osteotomy or osteosynthesis of the femur or acetabulum
- Patients with metabolic bone disease, other than osteoporosis
- Patients with inflammatory arthritis
- Obese patients where obesity is severe enough to affect the patient's ability to perform activities of daily living (BMI \> 40)
- Patients with active or suspected infection
- Patients with malignancy
- Patients unable to cooperate caused by language or psychosocial conditions
The study team makes the final eligibility decision.
Where it's taking place
- Kristiansund, Møre and Romsdal, Norway
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kristiansund, Møre and Romsdal, Norway. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.